Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 10/20 | 0.91 |
| ▸ | ESR2 | Q92731 | 9/20 | 0.91 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.91 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.91 |
| ▸ | AR | P10275 | 1/20 | 0.80 |
| ▸ | HPGD | P15428 | 1/20 | 0.80 |
| ▸ | TSHR | P16473 | 1/20 | 0.80 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.80 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.80 |
| ▸ | HTR6 | P50406 | 1/20 | 0.80 |
| ▸ | ESRRG | P62508 | 1/20 | 0.80 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.80 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.80 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | TYR | P14679 | 1/20 | 0.56 |
| ▸ | CA12 | O43570 | 1/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.55 |
| ▸ | CA2 | P00918 | 1/20 | 0.55 |
| ▸ | GLA | P06280 | 1/20 | 0.55 |
| ▸ | CA3 | P07451 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Phenol SCHEMBL1651212 | 1.00 | ESR1 (0.91) | ESR1ESR2CYP3A4ALDH1A1AR | |
| Bisphenol A SCHEMBL3813565 | 1.00 | ESR1 (0.91) | ESR1ESR2CYP3A4ALDH1A1AR | |
| Phenol SCHEMBL5691556 | 0.98 | ESR1 (0.95) | ESR1ESR2CYP3A4ALDH1A1AR | |
| Bisphenol A SCHEMBL30645577 | 0.98 | ESR1 (0.86) | ESR1ESR2CYP3A4ALDH1A1AR | |
| SCHEMBL51117 | 0.95 | ESR1 (1.00) | ESR1ESR2CYP3A4ALDH1A1AR | |
| SCHEMBL4310025 | 0.95 | ESR1 (1.00) | ESR1ESR2CYP3A4ALDH1A1AR | |
| Phenol SCHEMBL2417001 | 0.95 | ESR1 (0.91) | ESR1ESR2CYP3A4ALDH1A1AR | |
| SCHEMBL9353524 | 0.95 | ESR1 (1.00) | ESR1ESR2CYP3A4ALDH1A1AR | |
| Bisphenol A SCHEMBL28090475 | 0.95 | ESR1 (0.90) | ESR1ESR2CYP3A4ALDH1A1AR | |
| Bisphenol A SCHEMBL11200630 | 0.93 | ESR1 (0.79) | ESR1ESR2CYP3A4ALDH1A1AR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10894758-B2 | Method of catalysis for the production of bisphenol A | DDP Specialty Electronic Materials US, Inc. (US) | 2021-01-19 | — | — | US | claimed |
| US-20200339493-A1 | METHOD OF CATALYSIS | DDP SPECIALTY ELECTRONIC MAT US INC (US) | 2020-10-29 | — | — | US | claimed |
| EP-3707118-A1 | METHOD OF CATALYSIS | Dow Global Technologies LLC (US) | 2020-09-16 | — | — | EP | claimed |
| CN-109563235-A | Water-soluble α -diol sulfonated epoxy resin composition and preparation method thereof | 陶氏环球技术有限责任公司 | 2019-04-02 | — | — | CN | claimed |
| US-20140378715-A1 | USE OF A TREATED, PROMOTED ION EXCHANGE RESIN CATALYST | DDP SPECIALTY ELECTRONIC MATERIALS US 8, LLC | 2014-12-25 | — | — | US | claimed |
| US-8907138-B1 | Use of a treated, promoted ion exchange resin catalyst | ROHM AND HAAS COMPANY (US) | 2014-12-09 | — | — | US | claimed |
| EP-2776384-A1 | USE OF A TREATED, PROMOTED ION EXCHANGE RESIN CATALYST | Rohm and Haas Company (US) | 2014-09-17 | — | — | EP | claimed |
| WO-2013101502-A1 | USE OF A TREATED, PROMOTED ION EXCHANGE RESIN CATALYST | ROHM AND HAAS COMPANY (US) | 2013-07-04 | — | — | WO | claimed |
| EP-1569795-B1 | THERMOPLASTIC ARTICLE HAVING A DECORATIVE MATERIAL EMBEDDED THEREIN | EASTMAN CHEM CO (US) | 2008-09-03 | — | — | EP | claimed |
| EP-1575774-B1 | ARTICLES OF MANUFACTURE INCORPORATING POLYESTER/POLYCARBONATE BLENDS | EASTMAN CHEM CO (US) | 2008-08-13 | — | — | EP | claimed |
| EP-0178678-B1 | SINGLE PACKAGE SOLVENT RESISTANT ZINC RICH THERMOPLASTIC POLYHYDROXYETHER COATINGS | UNION CARBIDE CORPORATION (US) | 1991-07-03 | — | — | EP | claimed |
| EP-0226313-B1 | PARTIALLY CRYSTALLINE POLY(SULFONE ESTER) RESIN | ARCO CHEMICAL TECHNOLOGY, INC. (US) | 1990-12-27 | — | — | EP | claimed |
| EP-0173373-B1 | PROCESS FOR PREPARING HIGHER MOLECULAR WEIGHT EXPOXY RESINS | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1988-09-07 | — | — | EP | claimed |
| EP-0155469-B1 | EPOXY RESIN COMPOSITION AND A PROCESS FOR PREPARING LAMINATES THEREFROM | THE DOW CHEMICAL COMPANY (US) | 1988-07-20 | — | — | EP | claimed |
| EP-0141381-B1 | IMPROVED ZINC RICH COATINGS | UNION CARBIDE CORPORATION (US) | 1987-03-04 | — | — | EP | claimed |
| EP-0067855-B1 | BENZOATE ESTER TERMINATED POLYCARBONATE | GENERAL ELECTRIC COMPANY (US) | 1986-10-29 | — | — | EP | claimed |
| EP-0096906-B1 | HEAT-CURABLE EPOXY COMPOSITIONS AND THEIR USE IN PREPARING FORMED ARTICLES | SHELL INTERNATIONALE RESEARCHMAATSCHAPPIJ B.V. (NL) | 1986-04-02 | — | — | EP | claimed |
| EP-0024526-B1 | EPOXY BASED SYNTHETIC SOLDER | AMERICAN CYANAMID COMPANY (US) | 1984-06-13 | — | — | EP | claimed |
| EP-0043953-B1 | ALUMINIUM TRIHYDRATE MODIFIED ZINC-RICH COATINGS | UNION CARBIDE CORPORATION (US) | 1983-11-09 | — | — | EP | claimed |
| EP-0005858-B1 | PREPARATION OF POLYARYLATES | UNION CARBIDE CORPORATION (US) | 1983-05-11 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10894758-B2 | Method of catalysis for the production of bisphenol A | HPD, PCNA, HACL2 | ESR1 449/4885ESR2 714/4885CYP3A4 233/4885 |
| US-20200339493-A1 | METHOD OF CATALYSIS | HPD, PCNA, HACL2 | ESR1 2752/4885ESR2 3305/4885CYP3A4 491/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.